{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:23:13Z","timestamp":1773458593594,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.humimm.2016.06.005","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T12:09:29Z","timestamp":1465646969000},"page":"658-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature"],"prefix":"10.1016","volume":"77","author":[{"given":"Ying-Ying","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7913","key":"10.1016\/j.humimm.2016.06.005_b0005","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan\u2019s disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.humimm.2016.06.005_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2010.08442.x","article-title":"X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma","volume":"152","author":"Rezaei","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.humimm.2016.06.005_b0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/15513819109065466","article-title":"The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975\u20131990","volume":"11","author":"Purtilo","year":"1991","journal-title":"Pediatr. Pathol."},{"issue":"5","key":"10.1016\/j.humimm.2016.06.005_b0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/humu.9339","article-title":"Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease","volume":"25","author":"Erd\u00f5s","year":"2005","journal-title":"Hum. Mutation"},{"issue":"2","key":"10.1016\/j.humimm.2016.06.005_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat. Genet."},{"issue":"7115","key":"10.1016\/j.humimm.2016.06.005_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.humimm.2016.06.005_b0035","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2010-03-275909","article-title":"X-linked lymphoproliferative syndromes: brothers or distant cousins?","volume":"116","author":"Filipovich","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2016.06.005_b0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","article-title":"X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis","volume":"149","author":"Speckmann","year":"2013","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2016.06.005_b0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1442-200X.2012.03683.x","article-title":"SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis","volume":"54","author":"Yang","year":"2012","journal-title":"Pediatr. Int."},{"issue":"5","key":"10.1016\/j.humimm.2016.06.005_b0050","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1399-3038.2012.01282.x","article-title":"Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis","volume":"23","author":"Kanegane","year":"2012","journal-title":"Pediatr. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2016.06.005_b0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/sji.12103","article-title":"Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome","volume":"78","author":"Sun","year":"2013","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2016.06.005_b0060","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1521-4141(200006)30:6<1691::AID-IMMU1691>3.0.CO;2-K","article-title":"Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression","volume":"30","author":"Gilmour","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2016.06.005_b0065","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humimm.2016.06.005_b0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.humimm.2016.06.005_b0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.06.005_b0080","first-page":"435","article-title":"X-linked lymphoproliferative syndrome: reports of 2 cases","volume":"7","author":"Gong","year":"1992","journal-title":"Tianjin Med."},{"issue":"4","key":"10.1016\/j.humimm.2016.06.005_b0085","first-page":"244","article-title":"Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family","volume":"87","author":"Zhu","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.humimm.2016.06.005_b0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/pbc.23216","article-title":"Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"58","author":"Zhizhuo","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.humimm.2016.06.005_b0095","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humimm.2016.06.005_b0100","first-page":"416","article-title":"Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives","volume":"49","author":"Yang","year":"2011","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.humimm.2016.06.005_b0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2249.2001.01599.x","article-title":"X-linked lymphoproliferative disease: three atypical cases","volume":"126","author":"Nistala","year":"2001","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2016.06.005_b0110","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/pbc.25126","article-title":"Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1","volume":"61","author":"An","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"21","key":"10.1016\/j.humimm.2016.06.005_b0115","first-page":"1629","article-title":"Clinical features and mutational analysis of four cases of X-Linked lymphoproliferative syndrome","volume":"28","author":"Hu","year":"2013","journal-title":"Chin. J. Appl. Clin. Pediatr."},{"issue":"3","key":"10.1016\/j.humimm.2016.06.005_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10875-010-9493-3","article-title":"Distribution and clinical features of primary immunodeficiency diseases in Chinese children (2004\u20132009)","volume":"31","author":"Wang","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2016.06.005_b0125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/INF.0b013e31829aa9e9","article-title":"Distribution, clinical features and molecular analysis of primary immunodeficiency diseases in Chinese children: a single-center study from 2005 to 2011","volume":"32","author":"Zhang","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"5","key":"10.1016\/j.humimm.2016.06.005_b0130","first-page":"302","article-title":"Primary immunodeficiency in south China: clinical features and a genetic subanalysis of 138 children","volume":"23","author":"Zeng","year":"2013","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2016.06.005_b0135","first-page":"90","article-title":"Primary immunodeficiency in Hong Kong and the use of genetic analysis for diagnosis","volume":"11","author":"Lam","year":"2005","journal-title":"Hong Kong Med. J."},{"issue":"3","key":"10.1016\/j.humimm.2016.06.005_b0140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s10875-006-9013-7","article-title":"Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan","volume":"26","author":"Lee","year":"2006","journal-title":"J. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2016.06.005_b0145","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.imbio.2011.06.002","article-title":"Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985\u20132010","volume":"216","author":"Lee","year":"2011","journal-title":"Immunobiology"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916301148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916301148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:22:54Z","timestamp":1536654174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916301148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0198885916301148"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.06.005","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}